Sage Journals: Discover world-class research

Abstract

Objective

To evaluate the outcomes associated with two techniques of periorbital steroid administration in bilateral fronto-orbital advancement (FOA).

Design

Multi-institutional retrospective chart review

Setting

Two high volume, tertiary US craniofacial centers

Patients, Participants

Patients who underwent FOA between 2012 and 2021

Interventions

Patients were divided into three cohorts based on method of steroid administration. Groups GEL and INJ represent those who received steroids in the form of triamcinolone soaked gelfoam or direct injection of dilute triamcinolone to the frontal/periorbital region, respectively. Group NON did not receive any periorbital steroids.

Main Outcome Measure(s)

Peri-operative outcomes including hospital length of stay and complications were evaluated based on method of periorbital steroid administration. Variables predictive of infectious complications were assessed using stepwise logistic regression.

Results

Four hundred and twelve patients were included in our sample (INJ:249, GEL:87, NON:76). Patients in the INJ group had a higher ASA class (P < .001) while patients in the NON group were significantly more likely to be syndromic (P < .001) and have multisuture craniosynostosis (P < .001). Rate of infectious complications for each cohort were NON: 2.6%, INJ: 4.4%, and GEL: 10.3%. There was no significant difference between groups in hospital length of stay (P = .654) or rate of post-operative infectious complications (P = .061). Increased ASA class (P = .021), increased length of stay (P = .016), and increased intraoperative narcotics (P = .011) were independent predictors of infectious complications.

Conclusions

We identified a dose-dependent relationship between periorbital steroids and rate of postoperative infections, with key contributions from ASA class, hospital length of stay, and dose of intraoperative narcotics.

Keywords

craniosynostosis craniofacial surgery evidence-based practice outcomes quality improvement surgical technique surgical complications

Get full access to this article

View all access options for this article.

References

Assimes

Lessard

. The use of perioperative corticosteroids in craniomaxillofacial surgery. Plast Reconstr Surg. 1999;103(1):313‐321.

Hoefflin

. Decreasing prolonged swelling and pain associated with deep plane face lifts. Plast Reconstr Surg. 1992;90(6):1125. doi:https://doi.org/10.1097/00006534-199212000-00047.

Stone

. Tumescent technique with local anesthesia for liposuction. Plast Reconstr Surg. 1995;95(3):603. doi:https://doi.org/10.1097/00006534-199503000-00046.

Malhari

Sharma

Rattan

. Role of corticosteroids in reduction of post-operative oedema in craniofaciomaxillary surgery. J Evol Med Dent Sci. 2016;5(48):3090‐3104.

Wei

ATJ

Madsen

Al-Sheemy

Kumar

. Does perioperative steroid use improve clinical outcomes in open repair of craniosynostosis? J Craniofac Surg. 2015;26(1):226‐231. doi:https://doi.org/10.1097/SCS.0000000000001405.

Clune

Greene

Guo

, et al. Perioperative corticosteroid reduces hospital stay after fronto-orbital advancement. J Craniofac Surg. 2010;21(2):344‐348. doi:https://doi.org/10.1097/SCS.0B013E3181CF6103.

Neil-Dwyer

Evans

Jones

Hayward

. Tumescent steroid infiltration to reduce postoperative swelling after craniofacial surgery. Br J Plast Surg. 2001;54(7):565‐569. doi:https://doi.org/10.1054/BJPS.2001.3664.

Choi

Greensmith

Chatdokmaiprai

Holmes

Meara

. Tumescent steroid infiltration reduces postoperative eye closure after craniofacial surgery. Plast Reconstr Surg. 2008;122(1):30e‐32e.

Greene

. Guide to the elimination of orthopedic surgery surgical site infections: an executive summary of the association for professionals in infection control and epidemiology elimination guide. Am J Infect Control. 2012;40(4):384‐386. doi:https://doi.org/10.1016/J.AJIC.2011.05.011.

10.

Marchi

Pan

Gagliotti

, et al. The Italian national surgical site infection surveillance programme and its positive impact, 2009 to 2011. Euro Surveill. 2014;19(21). doi:https://doi.org/10.2807/1560-7917.ES2014.19.21.20815.

11.

Saunders

Perennec-Olivier

Jarno

, et al. Improving prediction of surgical site infection risk with multilevel modeling. PLoS One. 2014;9(5). doi:https://doi.org/10.1371/JOURNAL.PONE.0095295.

12.

Weber

Rutala

Miller

Huslage

Sickbert-Bennett

. Role of hospital surfaces in the transmission of emerging health care-associated pathogens: norovirus, Clostridium difficile, and Acinetobacter species. Am J Infect Control. 2010;38(5 Suppl 1). doi:https://doi.org/10.1016/J.AJIC.2010.04.196

13.

Jeon

Neidell

Jia

Sinisi

Larson

. On the role of length of stay in healthcare-associated bloodstream infection. Infect Control Hosp Epidemiol. 2012;33(12):1213. doi:https://doi.org/10.1086/668422.

14.

de Carvalho

RLR

Campos

de Franco

LMC

de Rocha

Ercole

. Incidence and risk factors for surgical site infection in general surgeries. Rev Lat Am Enfermagem. 2017;25. doi:https://doi.org/10.1590/1518-8345.1502.2848.

15.

Park

SSE

Barmettler

. Vision loss secondary to facial and periorbital steroid injection: a systematic review. Ophthal Plast Reconstr Surg. 2021;37(6):511‐521. doi:https://doi.org/10.1097/IOP.0000000000001910.

16.

Alberti

de Souza Vasconcellos

Petroianu

. Influence of local or systemic corticosteroids on skin wound healing resistance. Acta Cir Bras. 2012;27(4):296‐299. doi:https://doi.org/10.1590/S0102-86502012000400003.

17.

Ehrlich

Hunt

. The effects of cortisone and anabolic steroids on the tensile strength of healing wounds. Ann Surg. 1969;170(2):203. doi:https://doi.org/10.1097/00000658-196908000-00007.

18.

Baker

Whitaker

. Interference with wound healing by the local action of adrenocortical steroids. Endocrinology. 1950;46(6):544‐551. doi:https://doi.org/10.1210/ENDO-46-6-544.

19.

Howes

Plotz

Blunt

Ragan

. Retardation of wound healing by cortisone. Surgery. 1950;28(2):177‐181.

20.

Stephens

Dunphy

Hunt

. Effect of delayed administration of corticosteroids on wound contraction. Ann Surg. 1971;173(2):214. doi:https://doi.org/10.1097/00000658-197102000-00005.

21.

Carrico

Mehrhof

Cohen

. Biology of wound healing. Surg Clin North Am. 1984;64(4):721‐733. doi:https://doi.org/10.1016/S0039-6109(16)43388-8.

22.

Charalambous

Tryfonidis

Sadiq

Hirst

Paul

. Septic arthritis following intra-articular steroid injection of the knee–a survey of current practice regarding antiseptic technique used during intra-articular steroid injection of the knee. Clin Rheumatol. 2003;22(6):386‐390. doi: https://doi.org/10.1007/s10067-003-0757-7. Epub 2003 Oct 15. PMID: 14677011.

23.

Schairer

Nwachukwu

Mayman

Lyman

Jerabek

. Preoperative hip injections increase the rate of periprosthetic infection after total hip arthroplasty. J Arthroplasty. 2016;31(9):166‐169. e1. doi:https://doi.org/10.1016/J.ARTH.2016.04.008.

24.

Papavasiliou

Isaac

Marimuthu

Skyrme

Armitage

. Infection in knee replacements after previous injection of intra-articular steroid. J Bone Joint Surg Br. 2006;88(3):321‐323. doi:https://doi.org/10.1302/0301-620X.88B3.17136.

25.

Cancienne

Gwathmey

Werner

. Intraoperative corticosteroid injection at the time of knee arthroscopy is associated with increased postoperative infection rates in a large medicare population. Arthroscopy. 2016;32(1):90‐95. doi:https://doi.org/10.1016/J.ARTHRO.2015.09.003.

26.

Werner

Cancienne

Burrus

Park

Perumal

Cooper

. Risk of infection after intra-articular steroid injection at the time of ankle arthroscopy in a medicare population. Arthroscopy. 2016;32(2):350‐354. doi:https://doi.org/10.1016/J.ARTHRO.2015.07.029.

27.

Lutsky

Lucenti

Banner

Matzon

Beredjiklian

. The effect of intraoperative corticosteroid injections on the risk of surgical site infections for hand procedures. J Hand Surg Am. 2019;44(10):840‐845. e5. doi:https://doi.org/10.1016/J.JHSA.2019.07.004.

28.

Halaas

. Management of foreign bodies in the skin. Am Fam Physician. 2007;76(5):683‐688.

29.

Coutinho

Chapman

. The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights. Mol Cell Endocrinol. 2011;335(1):2‐13. https://doi.org/10.1016/j.mce.2010.04.005.

30.

Mitra

. Adverse effects of corticosteroids on bone metabolism: a review. PM & R: J Injury Funct Rehabil. 2011;3(5):466‐471. https://doi.org/10.1016/j.pmrj.2011.02.017.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

Eyeing Risks: A Critical Analysis of the Use of Periorbital Steroids in Fronto-orbital Advancement